First Header Logo Second Header Logo

Targeting Ras-RAF-ERK and its interactive pathways as a novel therapy for malignant gliomas.

Lo HW. Targeting Ras-RAF-ERK and its interactive pathways as a novel therapy for malignant gliomas. Curr Cancer Drug Targets. 2010 Dec; 10(8):840-8.

View in: PubMed